Literature DB >> 25941575

Is the scavenger receptor MARCO a new immune checkpoint?

Mohamed S Arredouani1.   

Abstract

Whereas macrophages use the scavenger receptor MARCO primarily in antimicrobial immunity by interacting with both exogenous and endogenous environments, in dendritic cells (DCs) MARCO is believed to pleiotropically link innate to adaptive immunity. MARCO exerts a significant modulatory effect on TLR-induced DC activation, thus offering novel avenues in cancer immunotherapy.

Entities:  

Keywords:  DC, dendritic cell; ICI, immune checkpoint inhibitor; LPS, lipopolysaccharide; MARCO, macrophage receptor with collagenous structure; PAMP, pathogen-associated molecular pattern; PKA, protein kinase A; SHP-2, Src-homology 2 domain (SH2)-containing; SR, scavenger receptor; TLR, Toll-like receptor; Toll-like receptor; cancer immunotherapy; dendritic cell activation; immune checkpoint inhibitor; scavenger receptor MARCO

Year:  2014        PMID： 25941575      PMCID： PMC4292731          DOI： 10.4161/21624011.2014.955709

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes.

Authors:  T Pikkarainen; A Brännström; K Tryggvason
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

2.  SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens.

Authors:  Subhankar Mukhopadhyay; Audrey Varin; Yunying Chen; Baoying Liu; Karl Tryggvason; Siamon Gordon
Journal:  Blood       Date:  2010-11-23       Impact factor: 22.113

3.  The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia.

Authors:  Francesca Granucci; Filippo Petralia; Matteo Urbano; Stefania Citterio; Francesco Di Tota; Laura Santambrogio; Paola Ricciardi-Castagnoli
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

4.  Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Authors:  Norimasa Matsushita; Hiroshi Komine; Annabelle Grolleau-Julius; Shari Pilon-Thomas; James J Mulé
Journal:  Cancer Immunol Immunother       Date:  2010-01-08       Impact factor: 6.968

5.  Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays.

Authors:  Annabelle Grolleau; David E Misek; Rork Kuick; Samir Hanash; James J Mulé
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

6.  Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation.

Authors:  Mohamed S Arredouani; Francesca Franco; Amy Imrich; Alexey Fedulov; Xin Lu; David Perkins; Raija Soininen; Karl Tryggvason; Steven D Shapiro; Lester Kobzik
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

7.  CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation.

Authors:  Fabiano Pinheiro da Silva; Meryem Aloulou; David Skurnik; Marc Benhamou; Antoine Andremont; Irineu T Velasco; Murilo Chiamolera; J Sjef Verbeek; Pierre Launay; Renato C Monteiro
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440

8.  In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination.

Authors:  Chih-Ping Mao; Liangmei He; Ya-Chea Tsai; Shiwen Peng; Tae Heung Kang; Xiaowu Pang; Archana Monie; Chien-Fu Hung; T-C Wu
Journal:  Cell Biosci       Date:  2011-01-18       Impact factor: 7.133

9.  MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.

Authors:  Dawn M E Bowdish; Kaori Sakamoto; Mi-Jeong Kim; Mariliis Kroos; Subhankar Mukhopadhyay; Cynthia A Leifer; Karl Tryggvason; Siamon Gordon; David G Russell
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

10.  The scavenger receptor MARCO modulates TLR-induced responses in dendritic cells.

Authors:  Haydn T Kissick; Laura K Dunn; Sanjukta Ghosh; Morris Nechama; Lester Kobzik; Mohamed S Arredouani
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240
  10 in total
  10 in total

1.  Repeated Exposure of Macrophages to Synthetic Amorphous Silica Induces Adaptive Proteome Changes and a Moderate Cell Activation.

Authors:  Anaelle Torres; Véronique Collin-Faure; Hélène Diemer; Christine Moriscot; Daphna Fenel; Benoît Gallet; Sarah Cianférani; Jacques-Aurélien Sergent; Thierry Rabilloud
Journal:  Nanomaterials (Basel)       Date:  2022-04-22       Impact factor: 5.719

Review 2.  Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

3.  Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.

Authors:  Andrew X Chen; Robyn D Gartrell; Junfei Zhao; Pavan S Upadhyayula; Wenting Zhao; Jinzhou Yuan; Hanna E Minns; Athanassios Dovas; Jeffrey N Bruce; Anna Lasorella; Antonio Iavarone; Peter Canoll; Peter A Sims; Raul Rabadan
Journal:  Genome Med       Date:  2021-05-19       Impact factor: 11.117

4.  Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model.

Authors:  Chongxu Zhang; Stephanie Chery; Aaron Lazerson; Norman H Altman; Robert Jackson; Greg Holt; Michael Campos; Andrew V Schally; Mehdi Mirsaeidi
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

Review 5.  Harnessing tumor-associated macrophages as aids for cancer immunotherapy.

Authors:  Xiaolei Li; Rui Liu; Xiao Su; Yongsha Pan; Xiaofeng Han; Changshun Shao; Yufang Shi
Journal:  Mol Cancer       Date:  2019-12-05       Impact factor: 27.401

Review 6.  Overcoming Immune Evasion in Melanoma.

Authors:  Kevinn Eddy; Suzie Chen
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 7.  Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance.

Authors:  Rossella Bellini; Fabrizia Bonacina; Giuseppe Danilo Norata
Journal:  Front Cardiovasc Med       Date:  2022-07-28

8.  Akkermansia muciniphila Reduces Peritonitis and Improves Intestinal Tissue Wound Healing after a Colonic Transmural Defect by a MyD88-Dependent Mechanism.

Authors:  Radu Bachmann; Matthias Van Hul; Pamela Baldin; Daniel Léonard; Nathalie M Delzenne; Clara Belzer; Janneke P Ouwerkerk; Dirk Repsilber; Ignacio Rangel; Alex Kartheuser; Robert Jan Brummer; Willem M De Vos; Patrice D Cani
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

9.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

10.  The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.

Authors:  Sebastian Lundgren; Emelie Karnevi; Jacob Elebro; Björn Nodin; Mikael C I Karlsson; Jakob Eberhard; Karin Leandersson; Karin Jirström
Journal:  J Transl Med       Date:  2017-07-03       Impact factor: 5.531
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.